A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive ...
This is a livestream recording of the NHS England board meeting that took place on 26 March 2026. This recording can be made available in a different format on request. Please contact us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results